For over 50 years, we've been turning "what if?" into "what's next." Since 1973, BrightFocus has sparked the boldest ideas in brain and eye research—many becoming today's breakthrough treatments and diagnostic tools. Here's how we're changing the game: ✔️ We provide

When Dave Palmer’s father began experiencing difficulty with day-to-day tasks due to vision loss from age-related macular degeneration (AMD), Dave and his wife Leanna started researching what they could do to help. That’s when the Palmers began donating to Macular

U.S. POINTER proves healthy behaviors protect your brain—even for high-risk people facing everyday challenges. Dr. Laura Baker breaks down the largest brain health study ever conducted. Watch & share with 3 friends: https://t.co/9WA29aHzSZ

With early support from BrightFocus’ Macular Degeneration Research program, Brian McKay, PhD, discovered that people taking L-DOPA for Parkinson’s disease had significantly lower rates of age-related macular degeneration (AMD). That finding led to his discovery of a protective

How close are we to using stem cell treatments for age-related macular degeneration (AMD)? Join our Macular Chat tomorrow, October 29, with Dr. Jeffrey Stern, co-founder of @NeuralStemCells. He'll cover the latest science, share clinical trial updates, and explain what these

"If you can't help the one you love, help the one you can." When the Sahyun family faced both vision loss and dementia diagnoses, this advice transformed their heartbreak into hope. Read about how they—and other families—are fueling Alzheimer’s research in our 2025 annual

🧠 Curious about the latest Alzheimer’s treatments? Our new infographic breaks down the FDA-approved therapies available today, from disease-modifying treatments to those that help manage symptoms. See at a glance how each drug works, how it’s administered, and which stage of

Stem cell research is opening new doors for treating age-related macular degeneration (AMD), a leading cause of vision loss. Join our Macular Chat on Wednesday, October 29, with Dr. Jeffrey Stern, co-founder of @NeuralStemCells. He'll break down the science, share clinical

What is National Estate Planning Awareness Week? It’s a time to reflect, plan ahead, and protect what matters most. ♥️ Nearly 2 out of 3 adults don’t have a will, but creating one is simpler than you think. With @FreeWill_HQ, it’s 100% free and only takes about 20 minutes:

🧠 Did you know your gut health could impact your Alzheimer's risk? Join Dr. Beau Ances from @WashU today (Oct 21) at 1 p.m. ET as he breaks down the emerging science connecting trillions of gut bacteria to brain health. Watch live and get your questions answered. ⤵️

New research is exploring how to restore vision after glaucoma damage. Dr. Lucy Q. Shen breaks down the science and shares what makes her hopeful about the future of treatment. 🔊 Listen here: https://t.co/mMzSyMuvoq #GlaucomaChat #Glaucoma #BrightFocusFoundation

Could the trillions of bacteria in your gut affect your brain health? 🧠🦠 Join Dr. Beau Ances of Washington University in St. Louis on Oct 21 at 1 p.m. ET to explore the connection between gut health and Alzheimer's disease. To discover what the gut microbiome is, how it

🔬 Research into macular degeneration is advancing fast—from earlier detection to new treatments. Drs. Bovenkamp and Rossi discuss the projects making an impact and where the field is headed next. Listen to our full Macular Chat: https://t.co/WTcgs9pc2D

Electronic implants in the retina or brain can restore partial vision in people who have lost the light-sensing cells in their eyes. This technology is offering hope to those with severe vision loss due to diseases like age-related macular degeneration (AMD). Learn more:

On this episode of Macular Chats, ophthalmologist Dr. Brian McKay and Dr. Murray Brilliant discuss what researchers have learned about nutritional supplements and age-related changes in the retina. They break down the evidence behind AREDS2 and discuss promising early research

That's a wrap on Glaucoma Fast Track 2025, where early-career researchers from around the world gathered in Atlanta to learn from experts, present their work, and build the networks that will carry glaucoma research forward. This was our fourth Fast Track workshop—and each

Scientists are exploring whether a class of diabetes medications might also help protect against Alzheimer's disease. GLP-1 drugs like liraglutide have shown some promise in early studies—improving cognitive function. But researchers say more work is needed. Larger clinical

Team BrightFocus Foundation is on the ground with top glaucoma researchers in Atlanta for our #GlaucomaFastTrack program, the official pre-symposium workshop to the International Society for Eye Research (ISER)/ BrightFocus Glaucoma Symposium. Glaucoma Fast Track brings

Tune in today (Oct 8) for our next Glaucoma Chat featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines. We'll also address common

If you have both dry eye and glaucoma, you're not alone, and relief is possible. Join us for our next Glaucoma Chat on Wednesday, Oct 8, featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including